You are here

2021 Poster Session: A Virtual Experience

2021 Poster Session: A Virtual Experience

We are excited to announce that the 2021 posters will be available for online viewing through December 31, 2021. As the window to view the posters are limited, we encourage everyone to register asap, to receive the max allotted time.

We have a total of 29 authors/presenters sharing their critical insights and research findings. 

Earn up to a max of 7.25 hours of CME depending on how many posters you choose to view. 

Instructions on how to access the posters and obtain CME will be included in your confirmation email. 

Costs:

  • CTMSS Members: $25 USD
  • Non-Members: $85 USD

All registrations will be checked for membership.

Click here to view a list of confirmed posters.


Acknowledgment of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgment of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must review each poster chosen and take up to 15 minutes to absorb the information and complete an evaluation form to receive a certificate of completion.

Complete all posters you wish to view before completing the evaluation.

If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.  

Physicians

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring material for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Objectives - After Attending This Program You Should Be Able To

  1. Identify evidence for various TMS treatment approaches compared to standard TMS approach
  2. Discuss the effectiveness of TMS in various populations and settings
  3. Discuss predictive biomarkers and/or clinical markers of response to repetitive transcranial magnetic stimulation (rTMS) treatment

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed on the website. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.

First Name

Last Name

Commercial Interest: Relationship

Scott

Aaronson

Neuronetics:Research Grant Site Principal Investigator,Janssen:Consultant,Sage Therapeutics:Consultant,Compass Pathways:Research Grant Site Principal Investigator,Genomind:Scientific/Medical Advisory Board Member,LivaNova:Consultant,Neurolief:Consultant,Neuronetics:Consultant,Compass Pathways:Research Grant Overall Principal Investigator

Paul

Croarkin

Neuronetics, Inc:Research Grant Site Principal Investigator,Pfizer, Inc:Research Grant Overall Principal Investigator,Assurerx Health:Other,Procter & Gamble Company:Consultant,Sunovian :Scientific/Medical Advisory Board Member,NeoSync:Research Grant Site Principal Investigator,MagVenture: Equipment Support ,Myriad Neuroscience:Consultant,Engrail Therapeutics:Scientific/Medical Advisory Board Member,Neuronetics:Equipment Support

Nancy

Donachie

Smart Health & Wellness Centers:Stock Shareholder,Salience TMS Neuro Solutions:Scientific/Medical Advisory Board Member,Smart Health & Wellness Centers:Scientific/Medical Advisory Board Member

David

Dunner

Neuronetics:Other Financial or Material Support/consultant,Cyberonics/Livanova:Other Financial or Material Support/Research support,Janssen:Consultant

Todd

Hutton

Neuronetics:Consultant,Southern California TMS Center:Stock Shareholder

Joseph

Kriske

Salience TMS Neuro Solutions:Stock Shareholder

Adonis

Maiquez

Commercial interest:Own BrainsWay TMS machine

Lucian

Manu

Research Funding:Research Grant Site Principal Investigator

Leigh

Neal

Smart TMS:Medical Director of Smart TMS

Leigh

Neal

Smart TMS:Medical Director of Smart TMS

Randy

Pardell

Neuronetics :Co-marketing

Randy

Pardell

Neuronetics :Co-marketing

Kenny

Perez

SuccessTMS:Consultant

Yiftach

Roth

BrainsWay Ltd.:Stock Shareholder

Debra

Stultz

Jazz Pharmaceticuls:Speakers Bureau,Harmony Biosciences:Speakers Bureau

ARON

TENDLER

Brainsway:Consultant,Brainsway:Stock Shareholder

July 15th, 2021 8:00 AM   through   December 31st, 2021 11:59 PM
Virtual Poster Session Costs
Non-Member $ 85.00
Timezone
Time Zone Pacific
Event Thumbnail
Thumbnail
On-Demand Webinar
Show event on Member Dashboard's "On-Demand Webinars" tab

Download iCalendar entry for this event. iCalendar feed for this event.